Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:MCBOTCMKTS:PURE On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeMCBMetropolitan Bank$65.16+0.7%$62.70$38.56▼$69.56$690.03M1.0892,689 shs114,415 shsPUREPURE Bioscience$0.11+31.7%$0.08$0.05▼$0.21$9.17M0.3514,708 shs6,879 shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceMCBMetropolitan Bank+0.64%+1.53%-0.10%+18.08%+66.04%PUREPURE Bioscience+31.71%+30.12%-17.56%+35.00%+43.67%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationMCBMetropolitan Bank3.4568 of 5 stars2.51.00.00.03.42.53.8PUREPURE Bioscience1.1978 of 5 stars0.05.00.00.02.71.70.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceMCBMetropolitan Bank 3.00Buy$77.0018.18% UpsidePUREPURE Bioscience 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest WINE, STCK, MCB, and PURE Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/16/2025MCBMetropolitan BankHovde GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform$75.00 ➝ $79.00(Data available from 6/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookMCBMetropolitan Bank$492.21M1.41$5.76 per share11.32$65.18 per share1.00PUREPURE Bioscience$1.96M6.17N/AN/A($0.04) per share-2.70Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateMCBMetropolitan Bank$66.69M$5.9111.027.58N/A13.49%10.53%1.02%7/17/2025 (Estimated)PUREPURE Bioscience-$3.35M-$0.04N/A∞N/A-147.72%N/A-334.78%N/ALatest WINE, STCK, MCB, and PURE EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/17/2025Q2 2025MCBMetropolitan Bank$1.62N/AN/AN/A$72.50 millionN/A6/16/2025Q3 2025PUREPURE BioscienceN/A-$0.01N/A-$0.01N/A$0.49 million4/21/2025Q1 2025MCBMetropolitan Bank$1.61$1.45-$0.16$1.45$67.62 million$70.59 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthMCBMetropolitan BankN/AN/AN/AN/AN/APUREPURE BioscienceN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioMCBMetropolitan Bank0.240.980.98PUREPURE BioscienceN/A1.080.56Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipMCBMetropolitan Bank79.83%PUREPURE BioscienceN/AInsider OwnershipCompanyInsider OwnershipMCBMetropolitan Bank6.09%PUREPURE Bioscience43.54%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableMCBMetropolitan Bank24010.66 million10.01 millionNot OptionablePUREPURE Bioscience10111.89 million63.17 millionNot OptionableWINE, STCK, MCB, and PURE HeadlinesRecent News About These CompaniesPURE Bioscience Reports Fiscal Third Quarter 2025 Financial ResultsJune 16, 2025 | businesswire.comPURE Bioscience Stock (OTC:PURE), Guidance and ForecastJune 13, 2025 | benzinga.comPURE Bioscience (OTC:PURE) Stock, Insider Trading ActivityJune 12, 2025 | benzinga.comPURE Bioscience innovates dairy, beverage membrane treatmentJune 4, 2025 | investing.comPURE Bioscience introduces new membrane treatment applicationJune 4, 2025 | dairyfoods.comPURE Bioscience Unveils Revolutionary Membrane Treatment Solution for the Dairy and Beverage IndustryJune 2, 2025 | businesswire.comMeridian Bioscience Congratulates Catherine Lufkin For Receiving Pure Earth's 2025 "Force Of Nature" AwardMarch 6, 2025 | finance.yahoo.comPURE Bioscience Announces a New Distribution Agreement With Hydrite Chemical CompanyJanuary 21, 2025 | finance.yahoo.comPURE Bioscience Unveils New Brand IdentityJanuary 9, 2025 | businesswire.comPURE Bioscience Reports Fiscal First Quarter 2025 Financial ResultsDecember 16, 2024 | businesswire.comWorld’s First NMN Manufacturer, MIRAILAB BIOSCIENCE, Launches NMN Supplements and Cosmetics in UAEDecember 5, 2024 | businesswire.comPURE Bioscience announces distribution agreement with AFCONovember 26, 2024 | wattagnet.comPURE Bioscience Announces Distribution Agreement with AFCO, a Zep CompanyNovember 20, 2024 | finance.yahoo.comPURE Bioscience enters multi-year distribution agreement with Quip LabsNovember 6, 2024 | pharmabiz.comThis is what it’s really like to have OCD, according to 4 people living with itNovember 1, 2024 | tpr.orgPURE Bioscience Announces Distribution Agreement with Quip LaboratoriesNovember 1, 2024 | businesswire.comPURE Bioscience (OTC:PURE) Stock, Short Interest ReportNovember 1, 2024 | benzinga.comPURE Bioscience Reports Fiscal 2024 Financial ResultsOctober 29, 2024 | businesswire.comPURE Bioscience, Madison Chemical Announce Distribution AgreementOctober 28, 2024 | cleanlink.comPURE Bioscience Announces Distribution Agreement with Madison Chemical Co., Inc.October 22, 2024 | finance.yahoo.comMedia Sentiment Over TimeWINE, STCK, MCB, and PURE Company DescriptionsMetropolitan Bank NYSE:MCB$65.16 +0.43 (+0.66%) Closing price 06/20/2025 03:59 PM EasternExtended Trading$65.02 -0.14 (-0.21%) As of 06/20/2025 04:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Metropolitan Bank Holding Corp. operates as the bank holding company for Metropolitan Commercial Bank that provides a range of business, commercial, and retail banking products and services to small businesses, middle-market enterprises, public entities, and individuals in the New York metropolitan area. The company offers checking, savings, term deposit, money market, demand deposit, and other interest-bearing transaction accounts. It also provides lending products, including commercial real estate, multi-family, construction, and one-to four-family real estate loans; commercial and industrial loans; consumer loans; acquisition and renovation loans; loans to refinance or return borrower equity; loans on owner-occupied properties; working capital lines of credit; trade finance and letters of credit; and term loans. In addition, the company offers cash management services, as well as online and mobile banking, ACH, remote deposit capture, and debit cards. The company was formerly known as Metbank Holding Corp. and changed its name to Metropolitan Bank Holding Corp. in January 2007. Metropolitan Bank Holding Corp. was incorporated in 1997 and is headquartered in New York, New York.PURE Bioscience OTCMKTS:PURE$0.11 +0.03 (+31.71%) As of 06/20/2025 03:43 PM EasternPURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds. It offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a food contact surface sanitizer and disinfectant; PURE Control, a food contact processing aid for fresh produce and raw poultry; PURE Multi-Purpose and Floor Cleaner Concentrate to clean various resilient surfaces, including floors, glass, and food contact surfaces; and PURE Multi-Purpose Hi-Foam Cleaner Concentrate to clean stainless steel equipment, resilient floors, walls, and painted surfaces. The company also provides Axen30, a hard surface disinfectant; Axenohl, an antimicrobial formulation for use as a raw material ingredient in the manufacturing of consumer and commercial disinfecting and sanitizing products; and SILVÉRION, an antimicrobial formulation that is used against bacteria, viruses, yeasts, and molds. PURE Bioscience, Inc. was incorporated in 1992 and is headquartered in Rancho Cucamonga, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas New All-Time Highs Coming for Broadcom? Wall Street Says Yes Super Micro Computer Stock's Rally Backed by Strong Financials Forget the Fed: Home Depot Is the Real Gauge of the U.S. Consumer 3 Reasons AMD Could Be the Hottest Stock of the Summer Analysts Keep Boosting Taiwan Semiconductor Stock—Here's Why Robinhood Director Sells Millions, But HOOD Stock Eyes Gains Coinbase Stock Pops as Senate Passes GENIUS Stablecoin Bill Overheated Market? Analysts Watch These Red Flags Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
